Boston Scientific to buy Swiss company for $435M

Boston Scientific Corp. has reached a deal to buy Swiss medical-device maker Symetis for $435 million in cash. Symetis makes devices that let physicians replace heart valves without cracking open a patient's chest. The market for such transcatheter-valve technology has heated up in recent years, though only two companies have approval to sell the devices in the U.S. Symetis, which has about 300 employees, is conducting a clinical trial it needs to seek European regulatory approval. Boston Scientific…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news